Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy

American Journal of Physiology. Renal Physiology
Stacy A Johnson, Robert F Spurney

Abstract

Diabetic nephropathy (DN) is a serious complication of both type 1 and type 2 diabetes mellitus. The disease is now the most common cause of end-stage kidney disease (ESKD) in developed countries, and both the incidence and prevalence of diabetes mellitus is increasing worldwide. Current treatments are directed at controlling hyperglycemia and hypertension, as well as blockade of the renin angiotensin system with angiotensin-converting enzyme inhibitors (ACEIs), and angiotensin receptor blockers. Despite these therapies, DN progresses to ESKD in many patients. As a result, much interest is focused on developing new therapies. It has been over two decades since ACEIs were shown to have beneficial effects in DN independent of their blood pressure-lowering actions. Since that time, our understanding of disease mechanisms in DN has evolved. In this review, we summarize major cell signaling pathways implicated in the pathogenesis of diabetic kidney disease, as well as emerging treatment strategies. The goal is to identify promising targets that might be translated into therapies for the treatment of patients with diabetic kidney disease.

References

Mar 1, 1992·American Journal of Hypertension·T HaakK H Usadel
Feb 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·V Vallon, H Osswald
Apr 4, 2001·The Journal of Clinical Investigation·R KomersS Anderson
Apr 28, 2001·Molecular and Cellular Endocrinology·C C GerhardtA D Strosberg
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Jan 5, 2002·Journal of Biochemistry·Futoshi ShibasakiHiroyuki Uchino
Mar 6, 2002·The Journal of Cell Biology·Valerie Horsley, Grace K Pavlath
Oct 22, 2002·American Journal of Physiology. Renal Physiology·Jennifer L GoochHanna E Abboud
Dec 14, 2002·Biochemical and Biophysical Research Communications·Sheldon ChenFuad N Ziyadeh
Mar 7, 2003·American Journal of Physiology. Renal Physiology·Rebecca R FosterSteven J Harper
May 20, 2003·Kidney International·Song WangKeith A Hruska
May 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter Sartipy, David J Loskutoff
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Ariela BenigniGiuseppe Remuzzi
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Daisuke KoyaMasakazu Haneda
Sep 17, 2003·Genes & Development·Patrick G HoganAnjana Rao
Sep 18, 2003·The Journal of Biological Chemistry·Kazuhiko TakahashiHidehito Kotani
Dec 18, 2003·American Journal of Physiology. Renal Physiology·Amy K BanesMario B Marrero
Dec 25, 2003·Diabetes Care·Mark E MolitchUNKNOWN American Diabetes Association
Dec 25, 2003·Journal of the American Society of Nephrology : JASN·H Thomas LeeCharles W Emala
Feb 11, 2004·Nature Medicine·Hirofumi NoguchiHideki Matsui
May 20, 2004·Kidney International·Bieke F SchrijversAn S De Vriese
Oct 7, 2004·Nature Cell Biology·Estela JacintoMichael N Hall
Apr 15, 2005·Journal of the American Society of Nephrology : JASN·Purificación Hernández-VargasCarmen Gómez-Guerrero
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Jul 13, 2005·Diabetes Research and Clinical Practice·Kei EndoKoji Shirai
Dec 1, 2005·Kidney International·Katrine Jordan SchjoedtHans-Henrik Parving
Dec 8, 2005·American Journal of Physiology. Renal Physiology·Alaa S AwadMark D Okusa
Dec 13, 2005·The Journal of Clinical Investigation·Stuart P WeisbergAnthony W Ferrante
Feb 24, 2006·Journal of the American Society of Nephrology : JASN·Thiemo PfabBerthold Hocher
Mar 11, 2006·American Journal of Physiology. Renal Physiology·Mario B MarreroDouglas C Eaton

❮ Previous
Next ❯

Citations

May 3, 2016·Environmental Toxicology and Pharmacology·Junxian YuXinyu Liu
Dec 8, 2017·British Medical Bulletin·Sagen Zac-Varghese, Peter Winocour
Apr 6, 2018·Journal of Dietary Supplements·Mandeep Kumar AroraPuspendra Kumar
Nov 3, 2016·Scientific Reports·Roderick J TanYouhua Liu
May 23, 2019·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Joanne E Murphy-Ullrich
Oct 25, 2017·Nature Reviews. Nephrology·Kengo AzushimaThomas M Coffman
Dec 7, 2016·Pharmacogenomics·Nicole K WilsonMibava Leducq Consortium
Feb 21, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Meng WangZhaoyun Zhang
Aug 2, 2018·Clinical and Experimental Nephrology·Krishnamurthy P GudehithluAshok K Singh
Jan 26, 2016·Current Opinion in Nephrology and Hypertension·Lili Zhou, Youhua Liu
Dec 27, 2019·Physiological Reports·Frederikke E SembachMette V Østergaard
Dec 28, 2019·Cells·Gentzon HallRobert F Spurney
Feb 15, 2017·BioMed Research International·Miaomiao LuErmin Wang
Oct 23, 2020·Pharmacological Reports : PR·Abdolhamid EsmaeeliMohammad Seyedabadi
Dec 22, 2020·The Journal of Experimental Medicine·Shuai HuZhihong Liu
Aug 21, 2020·Kidney International·Brittney M RushRoderick J Tan
May 16, 2020·Drug Discovery Today·Frederikke E SembachLisbeth N Fink
Mar 28, 2018·Advances in Chronic Kidney Disease·Samuel Mon-Wei Yu, Joseph V Bonventre
Aug 8, 2021·Journal of Clinical Medicine·Margherita SistoSabrina Lisi
Oct 2, 2021·Journal of Animal Physiology and Animal Nutrition·Akhand ManiJeena Gupta
Jan 26, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yan CuiYun Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.